1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene has been researched along with Liver Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braeuning, A; Dusek, J; Hirsova, P; Holas, O; Horvatova, A; Kucera, O; Linhartova, L; Micuda, S; Pavek, P; Skoda, J; Smutny, T | 1 |
Baer-Dubowska, W; Cichocki, M; Jodynis-Liebert, J; Murias, M; Wierzchowski, M | 1 |
2 other study(ies) available for 1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene and Liver Neoplasms
Article | Year |
---|---|
Stilbene compound trans-3,4,5,4´-tetramethoxystilbene, a potential anticancer drug, regulates constitutive androstane receptor (Car) target genes, but does not possess proliferative activity in mouse liver.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Aryl Hydrocarbon Hydroxylases; Binding Sites; Cell Proliferation; Constitutive Androstane Receptor; Cytochrome P450 Family 2; Gene Expression Regulation, Enzymologic; Gluconeogenesis; Hep G2 Cells; Hepatocytes; Humans; Lipogenesis; Liver; Liver Neoplasms; Male; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Pyridines; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Steroid Hydroxylases; Stilbenes | 2019 |
3,4,5,4'-trans-tetramethoxystilbene (DMU-212) modulates the activation of NF-κB, AP-1, and STAT3 transcription factors in rat liver carcinogenesis induced by initiation-promotion regimen.
Topics: Animals; Carcinogenesis; Cyclooxygenase 2; I-kappa B Proteins; Liver; Liver Neoplasms; Male; NF-kappa B; Nitric Oxide Synthase Type II; Rats, Wistar; STAT3 Transcription Factor; Stilbenes; Transcription Factor AP-1 | 2014 |